Free Trial
LON:FBT

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Share Price, News & Analysis

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation logo
GBX 1,595.90 -4.00 (-0.25%)
As of 09/12/2025

About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock (LON:FBT)

Key Stats

Today's Range
1,595.90
1,606.20
50-Day Range
1,464.60
1,613.30
52-Week Range
1,361
1,809.18
Volume
7,150 shs
Average Volume
7,747 shs
Market Capitalization
£654.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FBT Stock News Headlines

First Trust NYSE Arca Biotechnology UCITS ETF
Amundi NYSE Arca Gold BUGS UCITS ETF USD
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Net Asset Values(s)
Net Asset Value(s)
First Trust Energy Infr: Dividend Insights
Lyxor NYSE Arca Gold BUGS (DR) UCITS ETF (CD91)
First Trust NYSE Arca Biotech ETF
See More Headlines

FBT Stock Analysis - Frequently Asked Questions

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's stock was trading at GBX 1,625.60 on January 1st, 2025. Since then, FBT stock has decreased by 1.8% and is now trading at GBX 1,595.90.

Shares of FBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation investors own include Taylor Wimpey (TW), ARK Genomic Revolution ETF (ARKG), Bristol Myers Squibb (BMY), Johnson & Johnson (JNJ), ARK Innovation ETF (ARKK), Intel (INTC).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Software - Application
Sub-Industry
N/A
Current Symbol
LON:FBT
CIK
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
9.27

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
41,021,495
Free Float
N/A
Market Cap
£654.66 million
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (LON:FBT) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners